Opaleye Management Inc. Magenta Therapeutics, Inc. Transaction History

Opaleye Management Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.76 - $14.15 $862,784 - $1.25 Million	-88,400 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$7.66 - $13.38 $310,965 - $543,174	40,596 Added 84.92%	88,400 $1.05 Million
Q4 2020 Feb 12, 2021	BUY	$6.1 - $7.94 $291,604 - $379,563	47,804 New	47,804 $375,000
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $333,987 - $457,951	-51,225 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$6.18 - $10.76 $2.37 Million - $4.13 Million	-383,487 Reduced 88.22%	51,225 $385,000

Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $91,885 - $232,227	-15,238 Reduced 3.39%	434,712 $2.73 Million
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $589,096 - $1.03 Million	64,950 Added 16.87%	449,950 $6.73 Million
Q3 2019 Nov 14, 2019	SELL	$9.63 - $14.0 $1.44 Million - $2.1 Million	-150,000 Reduced 28.04%	385,000 $3.95 Million
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $335,000 - $441,750	25,000 Added 4.9%	535,000 $7.89 Million
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $28,500 - $98,500	5,000 Added 0.99%	510,000 $8.4 Million
Q4 2018 Feb 14, 2019	SELL	$5.57 - $11.65 $1.23 Million - $2.56 Million	-220,000 Reduced 30.34%	505,000 $2.88 Million
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $1.98 Million - $2.75 Million	175,000 Added 31.82%	725,000 $8.71 Million
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $7.43 Million - $7.99 Million	550,000 New	550,000 $7.43 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.